Liminatus Pharma, Inc.
Pharmaceuticals · FULLERTON, CA
PharmaceuticalsSEC Form D
Liminatus Pharma, Inc. filed a Form D with the U.S. Securities and Exchange Commission on June 18, 2026, reporting $1,861,920 raised.
Incorporated in Delaware and based in FULLERTON, CA, it operates in the Pharmaceuticals sector.
Companies file a Form D within 15 days of the first sale of securities in a private offering under Regulation D — an early, public signal that Liminatus Pharma, Inc. has raised capital from private investors.
Browse more recently funded companies in Pharmaceuticals.
Executives & Directors
- Chris KimExecutive Officer · Director
- Scott DamExecutive Officer
- Byong C. YooExecutive Officer
- Sang-jin Daniel LeeExecutive Officer
- Beom K. ChoiExecutive Officer
- Eun Sook LeeDirector
- Nicholas FernandezDirector
- Ji Yeon BaekDirector
Recently funded in Pharmaceuticals
Other companies that recently filed a Form D
$3.0MRaised
FibroBiologics, Inc.
$200.0KRaised
Balsam Pharmaceuticals Co
$750.0KRaised
Eos SENOLYTIX, Inc.
$384.8KRaised
Spine BioPharma, Inc.
$50.0KRaised